Glucosio E Sodio Cloruro Ii Galenica Senese

Glucosio E Sodio Cloruro Ii Galenica Senese is an injectable solution that contains sodium chloride and glucose monohydrate. It is supplied as a sterile intravenous fluid without a specified strength label. The preparation is classified as an electrolyte solution and is intended for use under medical supervision. It belongs to the volume expander and electrolyte replenisher therapeutic class and is marketed in the European Union.

Glucosio E Sodio Cloruro Ii Galenica Senese is used in clinical settings to manage fluid and electrolyte balance and to provide an energy source.

- Replacement of extracellular fluid losses due to dehydration, surgery, or trauma. - Correction of hyponatremia or other electrolyte disturbances. - Treatment of hypoglycemia when rapid glucose delivery is required. - Support of parenteral nutrition regimens as a source of glucose and sodium chloride. - Adjunctive therapy during blood transfusion to maintain circulatory volume.

The safety profile of the sodium chloride and glucose injection reflects the expected reactions to intravenous electrolyte solutions.

Common: - Mild pain or irritation at the injection site. - Transient increase in blood sodium levels. - Temporary rise in blood glucose concentration. - Mild nausea or vomiting.

Serious: - Hypernatremia leading to neurological symptoms. - Severe hyperglycemia or diabetic ketoacidosis in susceptible patients. - Fluid overload causing pulmonary edema. - Allergic or anaphylactic reaction to the solution components.

Clinicians should evaluate patient-specific factors before administering Glucosio E Sodio Cloruro Ii Galenica Senese.

- Assess baseline electrolyte and glucose levels to avoid overcorrection. - Use caution in patients with heart failure, renal impairment, or pulmonary disease due to risk of fluid overload. - Monitor for signs of hypernatremia or hyperglycemia during and after infusion. - Adjust infusion rate in neonates, infants, and the elderly. - Avoid rapid administration in patients with compromised vascular integrity. - Discontinue if an allergic reaction is suspected.

The intravenous solution may interact with other medications or clinical conditions.

Avoid: - Concomitant administration of hypertonic saline or high‑dose glucose solutions, which can exacerbate electrolyte imbalance. - Use with drugs that may cause fluid retention, such as corticosteroids, without careful monitoring.

Use with caution: - Diuretics, which can alter sodium balance and require electrolyte monitoring. - Insulin therapy, because rapid glucose infusion may affect glycemic control. - Cardiac glycosides, where changes in serum electrolytes can influence drug toxicity. - Anticoagulants, as large-volume infusions may affect coagulation parameters.